{"resourceType": "Group", "meta": {"versionId": "3", "lastUpdated": "2024-07-30T15:23:43.143Z", "profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/cohort-definition"]}, "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Sheyu Li"}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact", "valueRelatedArtifact": {"type": "cite-as", "citation": "Diabetes treatment medication [Database Entry: FHIR Group Resource]. Contributors: Sheyu Li [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 265092. Revised 2024-07-30. Available at: https://fevir.net/resources/Group/265092. Computable resource at: https://fevir.net/resources/Group/265092."}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-title", "valueString": "Diabetes treatment medication"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-url", "valueUri": "https://fevir.net/resources/Group/265092"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-publisher", "valueString": "Computable Publishing LLC"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-copyright", "valueMarkdown": "https://creativecommons.org/licenses/by-nc-sa/4.0/"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-contact", "valueContactDetail": {"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/combination-method", "valueCode": "any-of"}], "id": "265092", "characteristic": [{"code": {"text": "Drug class"}, "valueCodeableConcept": {"text": "SGLT-2 inhibitor"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "SGLT-2 inhibitors"}]}, {"code": {"text": "Drug class"}, "valueCodeableConcept": {"text": "GLP-1 receptr agonist"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "GLP-1 receptr agonists"}]}, {"code": {"text": "Drug class"}, "valueCodeableConcept": {"text": "DPP-4 inhibitor"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "DPP-4 inhibitors"}]}, {"code": {"text": "Drug class"}, "valueCodeableConcept": {"text": "thiazolidinedione"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "thiazolidinediones"}]}, {"code": {"text": "Drug class"}, "valueCodeableConcept": {"text": "sulfonylurea"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "sulfonylureas"}]}, {"code": {"text": "Drug class"}, "valueCodeableConcept": {"text": "metformin"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "metformin"}]}, {"code": {"text": "Drug class"}, "valueCodeableConcept": {"text": "\u03b1-glucosidase inhibitor"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "\u03b1-glucosidase inhibitors"}]}, {"code": {"text": "Drug class"}, "valueCodeableConcept": {"text": "meglitinide"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "meglitinides"}]}, {"code": {"text": "Drug class"}, "valueCodeableConcept": {"text": "insulin"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "insulins"}]}, {"code": {"text": "Drug class"}, "valueCodeableConcept": {"text": "dual GIP/GLP-1 receptor agonist"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "dual GIP/GLP-1 receptor agonists"}]}, {"code": {"text": "Drug class"}, "valueCodeableConcept": {"text": "non-steroidal mineralocorticoid receptor antagonist"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "non-steroidal mineralocorticoid receptor antagonists"}]}], "description": "SGLT-2 inhibitors, GLP-1 receptr agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, thiazolidinediones, sulfonylureas, metformin, \u03b1-glucosidase inhibitors, meglitinides, insulins, dual GIP/GLP-1 receptor agonists, or non-steroidal mineralocorticoid receptor antagonists", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net", "value": "265092", "assigner": {"display": "Computable Publishing LLC"}}], "text": {"status": "empty", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">[No data.]</div>"}, "membership": "definitional", "modifierExtension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-status", "valueCode": "active"}], "type": "animal"}